CSU:TSXConstellation Software Inc. Analysis
Data as of 2026-03-10 - not real-time
CA$2,975.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Constellation Software is trading around CAD 2,975, comfortably above its 20‑day (≈2,522) and 50‑day (≈2,752) simple moving averages but still well below the 200‑day average (≈3,854), underscoring a short‑term upside bias within a longer‑term bearish backdrop. The RSI of 66 signals momentum still intact, while the MACD histogram is firmly positive (+82), suggesting bullish pressure despite the overall trend flagging “bearish.” Valuation metrics are stretched – a trailing PE of 67.6 versus an industry average of 36.9 and a DCF‑derived fair value near CAD 2,518 – indicating the stock is currently priced above intrinsic estimates. Fundamentals remain solid: revenue grew 16% YoY to CAD 11.1 bn, operating margin sits at 17.2%, and free cash flow exceeds CAD 2.1 bn, supporting a low payout ratio of 12% and a modest dividend yield of 0.19%.
Recent material news includes a disclosed 9.7% stake acquisition in Texas‑based Sabre and the upcoming Q4 earnings webcast on March 10, which could provide fresh insight into acquisition integration and earnings momentum. The combination of strong cash generation, disciplined dividend policy, and continued acquisition activity suggests a medium‑to‑long‑term upside potential, yet the current premium valuation and elevated 30‑day volatility (~61%) warrant caution on the near‑term. Investors should weigh the bullish technical signals against the overvalued pricing and consider a phased approach aligned with upcoming earnings and any valuation correction.
Recent material news includes a disclosed 9.7% stake acquisition in Texas‑based Sabre and the upcoming Q4 earnings webcast on March 10, which could provide fresh insight into acquisition integration and earnings momentum. The combination of strong cash generation, disciplined dividend policy, and continued acquisition activity suggests a medium‑to‑long‑term upside potential, yet the current premium valuation and elevated 30‑day volatility (~61%) warrant caution on the near‑term. Investors should weigh the bullish technical signals against the overvalued pricing and consider a phased approach aligned with upcoming earnings and any valuation correction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term SMAs but below long‑term SMA200
- Bullish MACD histogram versus overall bearish trend
- High valuation relative to DCF and industry PE
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and operating margins
- Robust free cash flow supporting dividend sustainability
- Acquisition of Sabre stake indicating growth pipeline
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistent cash generation and low payout ratio
- Diversified geographic footprint reducing concentration risk
- Track record of successful vertical‑market software acquisitions
Key Metrics & Analysis
Financial Health
Revenue Growth16.00%
Profit Margin6.16%
P/E Ratio67.6
ROE20.45%
ROA8.12%
Debt/Equity132.63
P/B Ratio13.4
Op. Cash FlowCA$2.6B
Free Cash FlowCA$2.1B
Industry P/E36.8
Technical Analysis
TrendBearish
RSI66.1
SupportCA$2,196.00
ResistanceCA$2,999.49
MA 20CA$2,521.88
MA 50CA$2,752.04
MA 200CA$3,854.04
MACDBullish
VolumeIncreasing
Fear & Greed Index75.77
Valuation
Fair ValueCA$2,517.66
Target PriceCA$4,228.57
Upside/Downside42.14%
GradeOvervalued
TypeBlend
Dividend Yield0.19%
Risk Assessment
Beta0.71
Volatility60.78%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.